We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues New Draft Guidance on Clinical Trial Meta-Analysis
FDA Issues New Draft Guidance on Clinical Trial Meta-Analysis
The FDA may accept safety analyses drawn and projected out from pooled clinical trial data as long as sponsors have carefully planned their evaluations and are willing to show their work, the agency says in new draft guidance issued Tuesday.